Your browser doesn't support javascript.
loading
Preference for daily versus on-demand pre-exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real-world Oral PrEP Demonstration study.
Zhang, Jing; Xu, Jun-Jie; Wang, Hong-Yi; Huang, Xiao-Jie; Chen, Yao-Kai; Wang, Hui; Chu, Zhen-Xing; Hu, Qing-Hai; He, Xiao-Qing; Li, Yao; Zhang, Lu-Kun; Hu, Zhi-Li; Bao, Ran-Tong; Li, Shang-Cao; Li, Hang; Ding, Hai-Bo; Jiang, Yong-Jun; Geng, Wen-Qing; Sylvia, Sean; Shang, Hong.
Afiliação
  • Zhang J; NHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Xu JJ; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China.
  • Wang HY; Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, China.
  • Huang XJ; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Chen YK; NHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Wang H; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China.
  • Chu ZX; Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, China.
  • Hu QH; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • He XQ; NHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Li Y; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China.
  • Zhang LK; Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, China.
  • Hu ZL; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Bao RT; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Li SC; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Li H; Chongqing Public Health Medical Center, Chongqing, China.
  • Ding HB; Department of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Jiang YJ; NHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Geng WQ; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China.
  • Sylvia S; Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, China.
  • Shang H; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
J Int AIDS Soc ; 24(2): e25667, 2021 02.
Article em En | MEDLINE | ID: mdl-33586841
ABSTRACT

INTRODUCTION:

This study explores the preference for daily versus on-demand pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in developing countries when both regimens are available.

METHODS:

From 11 December 2018 to 19 October 2019, we recruited MSM for an open-label real-world PrEP demonstration study in four major cities in China. Subjects selected their preferred PrEP (oral tenofovir/emtricitabine) regimen (daily vs. on-demand) at recruitment and underwent on-site screening before initiation of PrEP. We used logistic regression to assess preference for daily PrEP and correlates.

RESULTS:

Of 1933 recruited MSM, the median age was 29 years, 7.6% was currently married to or living with a female; the median number of male sexual partners was four and 6.1% had used post-exposure prophylaxis (PEP) in the previous six months. HIV infection risk was subjectively determined as very high (>75%) in 7.0% of subjects, high (50% to 75%) in 13.3%, moderate (25% to 49%) in 31.5% and low or none (0% to 24%) in 48.1%. On average, participants preferred on-demand PrEP over daily PrEP (1104 (57.1%) versus 829 (42.9%)) at recruitment. In multivariable analysis, currently being married to or living with a female was associated with 14.6 percentage points lower preference for daily PrEP (marginal effect = -0.146 [95% CI -0.230, -0.062], p = 0.001); whereas the number of male sexual partners (marginal effect = 0.003 [95% CI 0.000, 0.005], p = 0.034) and a subjective assessment of being very high risk of HIV infection (vs. low and no risk, marginal effect size = 0.105 [95% CI 0.012, 0.198], p = 0.027) were associated with increased preference for daily versus on-demand PrEP. Among the 1933 potential participants, 721 (37.3%) did not attend the subsequent on-site screening. Lower-income, lower education level, lower subjective expected risk of HIV infection risk and younger age positively correlated with the absence of on-site screening.

CONCLUSIONS:

MSM in China prefer both daily and on-demand PrEP when both regimens are provided free. Social structural factors and subjective risk of HIV infection have significant impacts on PrEP preference and use. The upcoming national PrEP guideline should consider incorporating both regimens and the correlates to help implement PrEP in China.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Tenofovir / Emtricitabina Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Tenofovir / Emtricitabina Idioma: En Ano de publicação: 2021 Tipo de documento: Article